5398 慕康生醫歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 52.59% | 21.79% | 30.28% | 24.10% |
| 2025Q1 | -6.73% | -54.54% | -47.26% | -38.02% |
| 2024Q4 | 30.64% | -0.91% | 1.11% | -2.31% |
| 2024Q3 | 35.47% | 7.25% | 7.54% | 3.92% |
| 2024Q2 | 40.68% | 7.99% | 13.17% | 11.91% |
| 2024Q1 | 34.64% | -8.86% | 3.52% | 3.86% |
| 2023Q4 | 6.68% | -39.29% | -34.90% | -35.69% |
| 2023Q3 | 20.59% | -16.41% | -9.44% | -9.98% |
| 2023Q2 | 25.76% | -8.34% | 0.81% | 0.31% |
| 2023Q1 | 12.30% | -27.80% | -27.54% | -28.11% |
| 2022Q4 | 18.69% | -6.68% | -8.63% | -9.21% |
| 2022Q3 | 23.01% | -7.96% | 0.38% | -0.40% |
| 2022Q2 | 30.66% | 1.50% | 8.24% | 7.66% |
| 2022Q1 | 31.25% | -6.52% | -7.02% | -8.17% |
| 2021Q4 | 28.05% | -9.21% | -3.04% | -4.43% |
| 2021Q3 | 35.94% | 6.16% | 2.59% | 0.10% |
| 2021Q2 | 32.81% | 14.55% | 9.49% | 8.74% |
| 2021Q1 | 36.38% | 7.53% | 9.59% | 8.54% |
| 2020Q4 | 33.40% | 6.14% | 10.98% | 10.59% |
| 2020Q3 | 33.86% | 3.02% | -0.62% | -0.78% |
| 2020Q2 | 33.90% | 0.03% | 2.99% | 2.93% |